U.S. conducts bird flu vaccine trial
-
Last Update: 2020-07-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
the U.SFood and Drug Administrationreleased a report on theof the 26th
the first U.SH5N1 avian influenza vaccine is less than expectedthe reportsurvey of 45
2
0 vaccinators showed that the bird flu vaccine was safe and harmless, but only 45 percent of all adults who received the highest dose of the vaccine were immunizedThe New England Journal of Medicine2
March 0006, said the vaccine's interim results showed that 57 percent of people received a second vaccination2eight days after being immunizedExplaining the discrepancy between the two findings, Sanofi, which developed the vaccine, said the first survey applied medium-term data, while the latest survey used a of stricter standards to obtain the final results Sanofi stressed that the findings still show that vaccine efficacy is greater than risk According to the data released, vaccinators need to be vaccinated at 90 micrograms, compared with 15 micrograms for regular winter flu In addition, the general seasonal influenza vaccine is usually as high as 75 to 90 per cent of adults under 65 years of age However, the relevant agencies have begun to develop complementary drugs for the vaccine to improve the effectiveness of vaccine immunization and reduce the amount of vaccinations According to the World Health Organization, H5N1 avian influenza has killed at least 167 people worldwide since the outbreak began 2003 (
Xinhua Provides without permission, is strictly prohibited from reprinting)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
